Agents and methods for treatment and diagnosis of ocular disorders [Expired]

Michael Thiel; Heddy Zola; Douglas Coster; Keryn Williams

Agents and methods for treatment and diagnosis of ocular disorders [Expired]

Michael Thiel (Inventor), Heddy Zola (Inventor), Douglas Coster (Inventor), Keryn Williams (Inventor)

Research output: Patent

Abstract

A method of treating an ocular disorder is disclosed, comprising administering to a patient in need of such treatment, an effective amount of a sub-immunoglobulin antigen-binding molecule that is immuno-interactive with a target antigen associated with the disorder. The invention is also directed to compositions comprising this sub-immunoglobulin antigen-binding molecule and to a method of diagnosing an ocular condition using such molecule.

Original language	English
Patent number	US 6773916 B1
Publication status	Published - 2004

Access to Document

https://patents.google.com/patent/US6773916B1

Cite this

@misc{3b035879d25049d3ab38f8575ce8d3dc,

title = "Agents and methods for treatment and diagnosis of ocular disorders [Expired]",

abstract = "A method of treating an ocular disorder is disclosed, comprising administering to a patient in need of such treatment, an effective amount of a sub-immunoglobulin antigen-binding molecule that is immuno-interactive with a target antigen associated with the disorder. The invention is also directed to compositions comprising this sub-immunoglobulin antigen-binding molecule and to a method of diagnosing an ocular condition using such molecule.",

author = "Michael Thiel and Heddy Zola and Douglas Coster and Keryn Williams",

year = "2004",

language = "English",

type = "Patent",

note = "US 6773916 B1",

}

TY - PAT

T1 - Agents and methods for treatment and diagnosis of ocular disorders [Expired]

AU - Thiel, Michael

AU - Zola, Heddy

AU - Coster, Douglas

AU - Williams, Keryn

PY - 2004

Y1 - 2004

N2 - A method of treating an ocular disorder is disclosed, comprising administering to a patient in need of such treatment, an effective amount of a sub-immunoglobulin antigen-binding molecule that is immuno-interactive with a target antigen associated with the disorder. The invention is also directed to compositions comprising this sub-immunoglobulin antigen-binding molecule and to a method of diagnosing an ocular condition using such molecule.

AB - A method of treating an ocular disorder is disclosed, comprising administering to a patient in need of such treatment, an effective amount of a sub-immunoglobulin antigen-binding molecule that is immuno-interactive with a target antigen associated with the disorder. The invention is also directed to compositions comprising this sub-immunoglobulin antigen-binding molecule and to a method of diagnosing an ocular condition using such molecule.

M3 - Patent

M1 - US 6773916 B1

ER -

Agents and methods for treatment and diagnosis of ocular disorders [Expired]

Abstract

Access to Document

Fingerprint

Cite this